Chatani M - Search Results

1

Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in nasopharyngeal carcinoma.

Chatani M, Teshima T, Inoue T, Yoshino K, Ikegami N, Hirai K, Shimakage M. Chatani M, et al. Laryngoscope. 1991 Jun;101(6 Pt 1):626-9. doi: 10.1288/00005537-199106000-00009. Laryngoscope. 1991. PMID: 1645832

2

Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma.

Shimakage M, Chatani M, Ikegami N, Hirai K. Shimakage M, et al. Among authors: chatani m. Jpn J Cancer Res. 1989 Jul;80(7):612-6. doi: 10.1111/j.1349-7006.1989.tb01685.x. Jpn J Cancer Res. 1989. PMID: 2551868 Free PMC article.

3

Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.

Shimakage M, Ikegami N, Chatani M, Yoshino K, Sato T. Shimakage M, et al. Among authors: chatani m. Biken J. 1987 Jun;30(2):45-51. Biken J. 1987. PMID: 2830879

4

Radiation therapy for carcinoma of the hypopharynx with special reference to nodal control.

Teshima T, Chatani M, Inoue T, Miyahara H, Sato T. Teshima T, et al. Among authors: chatani m. Laryngoscope. 1988 May;98(5):564-7. doi: 10.1288/00005537-198805000-00018. Laryngoscope. 1988. PMID: 3362021

5

Proper use of serum antibody titres against Epstein-Barr virus in nasopharyngeal carcinoma: IgA/virus capsid antigen for diagnosis and EBV-related nuclear antigen-2 for follow-up.

Shimakage M, Dezawa T, Chatani M. Shimakage M, et al. Among authors: chatani m. Acta Otolaryngol. 2000 Jan;120(1):100-4. doi: 10.1080/00016480060203325. Acta Otolaryngol. 2000. PMID: 10779195

6

A prospective randomized study concerning to the point A dose in high-dose rate intracavitary radiation therapy for carcinoma of the uterine cervix.

Chatani M, Teshima T, Inoue T. Chatani M, et al. Strahlenther Onkol. 1991 Dec;167(12):701-7. Strahlenther Onkol. 1991. PMID: 1763406 Clinical Trial.

7

[Radiation therapy for prostatic cancer].

Teshima T, Chatani M, Inoue T, Usami M, Kotake T. Teshima T, et al. Among authors: chatani m. Nihon Gan Chiryo Gakkai Shi. 1990 Jul 20;25(7):1404-9. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2212832 Japanese.

8

Radiation therapy for early glottic cancer (T1N0M0): II. Prospective randomized study concerning radiation field.

Teshima T, Chatani M, Inoue T. Teshima T, et al. Among authors: chatani m. Int J Radiat Oncol Biol Phys. 1990 Jan;18(1):119-23. doi: 10.1016/0360-3016(90)90275-o. Int J Radiat Oncol Biol Phys. 1990. PMID: 2404917 Clinical Trial.

9

Radiation therapy for early glottic cancer (T1N0M0): I. Results of conventional open field technique.

Teshima T, Chatani M, Inoue T. Teshima T, et al. Among authors: chatani m. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1199-202. doi: 10.1016/0360-3016(89)90526-9. Int J Radiat Oncol Biol Phys. 1989. PMID: 2513291

10

[Prognostic factors in patients with brain metastases from lung carcinoma].

Chatani M, Teshima T, Inoue T. Chatani M, et al. Gan No Rinsho. 1989 Oct;35(13):1596-601. Gan No Rinsho. 1989. PMID: 2585731 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters